A new study led by the University of Southampton has found that using temporary nursing staff to fill rotas only partially combats an increased risk of patient death associated with staff shortages.
J&J’s Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded
Johnson & Johnson’s streak of trial wins for its blockbuster drug Tremfya has come to an end. The blockbuster drug failed in a Phase 2